Planned Parenthood VP Informs Court that the Organization’s Assets Exceed $1 Billion

ROGUEREVIEW.NET


Melvin Galloway, the Executive Vice President and Chief Operating Officer of Planned Parenthood Federation of America and Planned Parenthood Action Fund, testified in court about the organization’s assets. Planned Parenthood’s civil case against the Center for Medical Progress involves the abortion provider suing the CMP to cover the extra security expenses Planned Parenthood claims had to be taken due to the CMP’s undercover videos. But as Galloway informed the court under oath, Planned Parenthood’s total assets are about $1.2 billion.

Galloway’s responsibilities include overseeing Planned Parenthood’s financial and security operations. While he hired a bodyguard for Deborah Nucatola – Planned Parenthood’s former medical director – upon the first video’s release, Galloway admitted even he wondered about Planned Parenthood’s guilt in selling fetal body parts.

You ask yourself: what did we do? What happened?

While he told the court the CMP videos caused him to approve extra security measures for Planned Parenthood events, a cross-examination by the defense showed a couple security invoices were dated before 2015. This would’ve been before the CMP videos were even released, and Galloway admitted those invoices shouldn’t have been included in Planned Parenthood’s list of damages in their lawsuit against CMP.

The defense also pointed out that abortion industry conferences have “a mere handful of new vendors” applying at a time. Planned Parenthood failed to follow proper vetting procedures in this case, and the CMP shouldn’t be expected to pay for security upgrades.

When asked about Planned Parenthood’s budget, Galloway testified the organization’s assets were about $1.2 billion. The defense was skeptical that Planned Parenthood didn’t have the resources to implement security measures, and Galloway confessed he didn’t know if Planned Parenthood could have afforded security upgrades before the CMP videos came out.

The Center for Medical Progress trial will resume next week.


Leave a Reply

Your email address will not be published.